Daniel Grossman focuses his research on both clinical and social science studies aimed at improving access to contraception and safe abortion in the United States, Latin America, and sub-Saharan Africa, as well as evaluating the impact of integrating reproductive health and HIV services. He has served on committees for professional organizations such as the American Public Health Association and the American College of Obstetricians and Gynecologists. As a faculty member in the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF, Dan performs clinical work at Zuckerberg San Francisco General Hospital. He is also a Senior Advisor with Ibis Reproductive Health. Dan received his Bachelor of Science in Molecular Biophysics and Biochemistry from Yale University and an MD from Stanford University. He completed his residency in Obstetrics and Gynecology at UCSF.
February 12, 2021
Constant D Endler M Grossman D Petro G Patel M. Immediate versus delayed insertion of the copper intrauterine device after medical abortion at 17-20 gestational weeks: a randomised controlled trial. February 2021. BMJ Sexual & Reproductive Health, Epub ahead of print.
January 13, 2021
Dragoman MV Grossman D Nguyen MH Habib N Kapp N Tamang A Bessenaar T Duong LD Gautam J Yoko JL Hong M Gulmezoglu M. Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial. January 2021. Contraception, 103(3):163-170.
January 11, 2021
Grindlay K Wollum A Karver J Grossman D. Over-the-counter oral contraceptive use among women in Mexico: results from a national survey. January 2021. BMJ Sexual & Reproductive Health, [Epub ahead of print].
January 4, 2021
White K Bhavik Kumar Goyal V Wallace RR Roberts SCM Grossman D. Changes in abortion in Texas following an executive order ban during the coronavirus pandemic. January 2021. JAMA Internal Medicine, 325(7):691-693.
December 23, 2020
Kohn JE Snow JL Grossman D Thompson TA Seymour JW Simons HR. Introduction of telemedicine for medication abortion: changes in service delivery patterns in two U.S. states. December 2020. Contraception, 103(3):151-156.
December 18, 2020
Ralph LJ Foster DG Biggs MA Samari G Upadhyay UD Gerdts C Grossman D. Prevalence of self-managed abortion among women of reproductive age in the United States. December 2020. JAMA, 3(12):e2029245.